Login / Signup

The Management of Hypercholesterolemia in Patients with Neuromuscular Disorder.

Wann Jia LohGerald F Watts
Published in: Current atherosclerosis reports (2023)
Patients with both NMD and hypercholesterolemia may be particularly disadvantaged owing to the toxic effects of cholesterol-lowering therapy and the inability to take medication. Specifically, the management of hypercholesterolemia in patients with NMD is complicated by the increased risk of statin-related myotoxicity and concerns that statins may aggravate or possibly induce the onset of a specific NMD. The most severe form of statin-related myotoxicity is immune-mediated necrotizing myopathy. Management of hypercholesterolemia in patients with NMDs include treating modifiable factors, consideration of toxicity risk of statin, use of non-statin lipid lowering agents, noting possible drug interactions, and careful monitoring.
Keyphrases
  • low density lipoprotein
  • cardiovascular disease
  • coronary artery disease
  • cardiovascular events
  • healthcare
  • stem cells
  • oxidative stress
  • adverse drug